Menu
Recruiting NCT05873608

Communication Issues in Patient and Provider Discussions of Immunotherapy

No phase Interventional Hematopoietic and Lymphoid System Neoplasm Malignant Solid Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Educational video, Interview, Observation.
Who it may be relevant to
Registry conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Communication Issues in Patient/Provider Discussions of Immunotherapy

Overview

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Detailed description

PRIMARY OBJECTIVES:

I. To identify misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources and assess if these misestimations persist post-provider conversation about immunotherapy.

II. To qualitatively describe patient reported misunderstandings and to assess patient understanding of technical terms and metaphors used in the immunotherapy conversation.

III. To identify provider and patient preferences for information to be communicated about immunotherapy.

IV. Develop videos that describe immunotherapy and test their efficacy in improving understanding using pre and post methodology.

OUTLINE:

Patients and their providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes. Understanding of educational videos is then tested.

Interventions

  • Other Educational video
    Testing an educational video
  • Other Interview
    Participate in interview
  • Other Observation
    Undergo observation

Primary outcome measures

  • Misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources [Time frame: Up to 4 years]
  • Qualitatively describe patient reported misunderstandings [Time frame: Up to 4 years]
  • Provider and patient preferences for information to be communicated about immunotherapy [Time frame: Up to 4 years]
  • Correct definition rates (pre- versus post-video) [Time frame: Up to 4 years]

Eligibility criteria

Inclusion criteria

  • AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
  • AIM 4: Any cancer patient

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 2 centers
  • Emory University Hospital/Winship Cancer Institute — Atlanta
  • Atlanta VA Medical Center — Decatur

Identifiers

NCT: NCT05873608 · IRB00091198 · NCI-2020-00828 · IRB00091198 · WINSHIP3293-16 · P01CA257906 · P30CA138292

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗